GlobeNewswire Inc.··NaNxera Pharma Hits $10M Milestone with AbbVie on Neurology Drug Discovery
Nxera Pharma receives $10M payment from AbbVie for identifying validated drug molecules against neurological disease target using proprietary platform.
ABBVpharmaceutical developmentcollaboration